Brief: Humacyte Q3 Basic EPS USD -0.25
09/11/2023 21:01
Nov 09 (Reuters) - Humacyte Q3 net income USD -25.995 million. * Q3 operating income USD -24.622 million * Q3 operating expenses USD 24.622 million
Recent news on Humacyte
See all newsBrief: Humacyte Announces Lancet Digital Health Publication Of V007 Phase 3 Hemodialysis Access Trial Results
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Humacyte falls after wider-than-expected quarterly loss
Humacyte Inc reports results for the quarter ended June 30 - Earnings Summary